iqvia glp-1 prescriptions semaglutide tirzepatide q3 2024 Impact of the CVS formulary change: Trends in prescribing iqvia glp-1 prescriptions semaglutide tirzepatide
Description
Participants have also reported a decrease in cravings and an improved relationship with food, making the journey to weight loss not only effective but also sustainable
Youre experiencing body recomposition rather than straightforward weight loss
C., Thomas, S
Recently, an oral formulation of Wegovy and a new oral GLP-1, Foundayo (Lilly), were approved, which could increase adoption rates of these drugs even further
This marks the first FDA-authorized treatment for NPC, a rare cancer
